TKI therapy shows ‘excellent efficacy’ in Japanese CML population

A review of tyrosine kinase inhibitor therapy in Japanese patients with chronic myeloid leukaemia demonstrates high rates of treatment response and good outcomes but highlights the various issues associated with treatment discontinuation.
Source: MedWire News - Category: Consumer Health News Tags: Chronic myeloid leukaemia Source Type: news